364 related articles for article (PubMed ID: 25455766)
1. Investigation of a nanosuspension stabilized by Soluplus® to improve bioavailability.
Yang H; Teng F; Wang P; Tian B; Lin X; Hu X; Zhang L; Zhang K; Zhang Y; Tang X
Int J Pharm; 2014 Dec; 477(1-2):88-95. PubMed ID: 25455766
[TBL] [Abstract][Full Text] [Related]
2. Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo.
Linn M; Collnot EM; Djuric D; Hempel K; Fabian E; Kolter K; Lehr CM
Eur J Pharm Sci; 2012 Feb; 45(3):336-43. PubMed ID: 22172603
[TBL] [Abstract][Full Text] [Related]
3. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.
Zhang K; Yu H; Luo Q; Yang S; Lin X; Zhang Y; Tian B; Tang X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1285-92. PubMed ID: 23562534
[TBL] [Abstract][Full Text] [Related]
4. A carbohydrate polymer is a critical variable in the formulation of drug nanocrystals: a case study of idebenone.
Ma M; Zhang G; Li W; Li M; Fu Q; He Z
Expert Opin Drug Deliv; 2019 Dec; 16(12):1403-1411. PubMed ID: 31622561
[No Abstract] [Full Text] [Related]
5. Fabrication of fenofibrate nanocrystals by probe sonication method for enhancement of dissolution rate and oral bioavailability.
Ige PP; Baria RK; Gattani SG
Colloids Surf B Biointerfaces; 2013 Aug; 108():366-73. PubMed ID: 23602990
[TBL] [Abstract][Full Text] [Related]
6. Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth.
Ghosh I; Bose S; Vippagunta R; Harmon F
Int J Pharm; 2011 May; 409(1-2):260-8. PubMed ID: 21371540
[TBL] [Abstract][Full Text] [Related]
7. A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes.
Patel PJ; Gajera BY; Dave RH
Drug Dev Ind Pharm; 2018 Dec; 44(12):1942-1952. PubMed ID: 30027778
[TBL] [Abstract][Full Text] [Related]
8. Solubility and dissolution rate enhancement of ibuprofen by co-milling with polymeric excipients.
Hussain A; Smith G; Khan KA; Bukhari NI; Pedge NI; Ermolina I
Eur J Pharm Sci; 2018 Oct; 123():395-403. PubMed ID: 30076953
[TBL] [Abstract][Full Text] [Related]
9. Improved dissolution rate and bioavailability of fenofibrate pellets prepared by wet-milled-drug layering.
Wang P; Luo Q; Miao Y; Ying L; He H; Cai C; Tang X
Drug Dev Ind Pharm; 2012 Nov; 38(11):1344-53. PubMed ID: 22283480
[TBL] [Abstract][Full Text] [Related]
10. Nanosuspensions as delivery system for gambogenic acid: characterization and in vitro/in vivo evaluation.
Yuan H; Li X; Zhang C; Pan W; Liang Y; Chen Y; Chen W; Liu L; Wang X
Drug Deliv; 2016 Oct; 23(8):2772-2779. PubMed ID: 26292058
[TBL] [Abstract][Full Text] [Related]
11. Formulation, optimization and in vitro-in vivo evaluation of febuxostat nanosuspension.
Ahuja BK; Jena SK; Paidi SK; Bagri S; Suresh S
Int J Pharm; 2015 Jan; 478(2):540-52. PubMed ID: 25490182
[TBL] [Abstract][Full Text] [Related]
12. Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation.
Hong C; Dang Y; Lin G; Yao Y; Li G; Ji G; Shen H; Xie Y
Int J Pharm; 2014 Dec; 477(1-2):251-60. PubMed ID: 25445518
[TBL] [Abstract][Full Text] [Related]
13. Physicochemical, Pharmacodynamic and Pharmacokinetic Characterization of Soluplus Stabilized Nanosuspension of Tacrolimus.
Varshosaz J; Minayian M; Yazdekhasti S
Curr Drug Deliv; 2017; 14(4):521-535. PubMed ID: 27697037
[TBL] [Abstract][Full Text] [Related]
14. A simple and low-energy method to prepare loratadine nanosuspensions for oral bioavailability improvement: preparation, characterization, and in vivo evaluation.
Yang D; Li R; Zhang F; Qin L; Peng F; Jiang S; He H; Lu X; Zhang P
Drug Deliv Transl Res; 2020 Feb; 10(1):192-201. PubMed ID: 31482518
[TBL] [Abstract][Full Text] [Related]
15. Improved solubility and oral bioavailability of apigenin via Soluplus/Pluronic F127 binary mixed micelles system.
Zhang Z; Cui C; Wei F; Lv H
Drug Dev Ind Pharm; 2017 Aug; 43(8):1276-1282. PubMed ID: 28358225
[TBL] [Abstract][Full Text] [Related]
16. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.
Sawant KK; Patel MH; Patel K
Drug Dev Ind Pharm; 2016; 42(5):758-68. PubMed ID: 26548349
[TBL] [Abstract][Full Text] [Related]
17. Fabrication of surfactant-stabilized nanosuspension of naringenin to surpass its poor physiochemical properties and low oral bioavailability.
Singh MK; Pooja D; Ravuri HG; Gunukula A; Kulhari H; Sistla R
Phytomedicine; 2018 Feb; 40():48-54. PubMed ID: 29496174
[TBL] [Abstract][Full Text] [Related]
18. Improved Oral Bioavailability of Lacidipine Using Nanosuspension Technology: Inferior in vitro Dissolution and Superior in vivo Drug Absorption versus Lacipil®.
Zhao J; Luo L; Fu Q; Guo B; Li Y; Geng Y; Wang J; Zhang T
Curr Drug Deliv; 2016; 13(5):764-73. PubMed ID: 25963306
[TBL] [Abstract][Full Text] [Related]
19. Formulation and drying of miconazole and itraconazole nanosuspensions.
Cerdeira AM; Mazzotti M; Gander B
Int J Pharm; 2013 Feb; 443(1-2):209-20. PubMed ID: 23291552
[TBL] [Abstract][Full Text] [Related]
20. Fast dissolution of poorly water soluble drugs from fluidized bed coated nanocomposites: Impact of carrier size.
Azad M; Moreno J; Bilgili E; Davé R
Int J Pharm; 2016 Nov; 513(1-2):319-331. PubMed ID: 27639622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
